“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."
The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients. The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here.
Team Pulsara: May 12, 2025
Think about a time you or a loved one were in a vulnerable position, navigating the complexities of illness or injury. Who was there, not only...
Audrey Peart: Apr 30, 2025
April Recap Optimize Patient Transfer WorkflowsOur newest package, Pulsara TRANSFER OPS, empowers teams to streamline communication within and across...
Team Pulsara: Apr 25, 2025
Leverage Existing Pulsara Capabilities for Streamlined Patient Movement Efficient patient transfers are the lifeblood of a well-functioning...
Brittney Nelson, BSN, RN, SCRN